A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer.

Trial Profile

A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Pemetrexed (Primary) ; Carboplatin
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2013 Actual end date Jun 2010 added as reported by ClinicalTrials.gov.
    • 03 Mar 2011 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 03 Mar 2011 Planned end date changed from 1 Sep 2010 to 1 Apr 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top